BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22247454)

  • 1. Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury.
    Park SS; Caballero S; Bauer G; Shibata B; Roth A; Fitzgerald PG; Forward KI; Zhou P; McGee J; Telander DG; Grant MB; Nolta JA
    Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):986-94. PubMed ID: 22247454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings.
    Park SS; Bauer G; Abedi M; Pontow S; Panorgias A; Jonnal R; Zawadzki RJ; Werner JS; Nolta J
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):81-9. PubMed ID: 25491299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal Administration of Human Bone Marrow CD34+ Stem Cells in a Murine Model of Retinal Degeneration.
    Moisseiev E; Smit-McBride Z; Oltjen S; Zhang P; Zawadzki RJ; Motta M; Murphy CJ; Cary W; Annett G; Nolta JA; Park SS
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4125-35. PubMed ID: 27537262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intravitreal injection of human CD34
    Yazdanyar A; Zhang P; Dolf C; Smit-McBride Z; Cary W; Nolta JA; Zawadzki RJ; Marsh-Armstrong N; Park SS
    Exp Eye Res; 2020 Jan; 190():107865. PubMed ID: 31682846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection.
    Wang J; Kimura T; Asada R; Harada S; Yokota S; Kawamoto Y; Fujimura Y; Tsuji T; Ikehara S; Sonoda Y
    Blood; 2003 Apr; 101(8):2924-31. PubMed ID: 12480697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human CD34(+)CXCR4(-) sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulation.
    Kollet O; Petit I; Kahn J; Samira S; Dar A; Peled A; Deutsch V; Gunetti M; Piacibello W; Nagler A; Lapidot T
    Blood; 2002 Oct; 100(8):2778-86. PubMed ID: 12351385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The observation of engraftment of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model by intra-bone marrow injection].
    Gao JT; Lu SH; Li YH; Yang Z; Xu J; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):361-5. PubMed ID: 19031735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells.
    Pflumio F; Izac B; Katz A; Shultz LD; Vainchenker W; Coulombel L
    Blood; 1996 Nov; 88(10):3731-40. PubMed ID: 8916937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras.
    Ramírez M; Rottman GA; Shultz LD; Civin CI
    Exp Hematol; 1998 Apr; 26(4):332-44. PubMed ID: 9546317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor stromal cells from human blood engraft in NOD/SCID mice.
    Goan SR; Junghahn I; Wissler M; Becker M; Aumann J; Just U; Martiny-Baron G; Fichtner I; Henschler R
    Blood; 2000 Dec; 96(12):3971-8. PubMed ID: 11090086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis.
    Xu M; Bruno E; Chao J; Ni H; Lindgren V; Nunez R; Mahmud N; Finazzi G; Fruchtman SM; Popat U; Liu E; Prchal JT; Rondelli D; Barosi G; Hoffman R
    Blood; 2005 Feb; 105(4):1699-705. PubMed ID: 15471948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subretinal versus intravitreal administration of human CD34+ bone marrow-derived stem cells in a rat model of inherited retinal degeneration.
    Park UC; Park SS; Kim BH; Park SW; Kim YJ; Cary W; Anderson JD; Nolta JA; Yu HG
    Ann Transl Med; 2021 Aug; 9(15):1275. PubMed ID: 34532412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of circulating CD34(+) cells with SDF-1alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential.
    Plett PA; Frankovitz SM; Wolber FM; Abonour R; Orschell-Traycoff CM
    Exp Hematol; 2002 Sep; 30(9):1061-9. PubMed ID: 12225798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and efficient homing of human CD34(+)CD38(-/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice.
    Kollet O; Spiegel A; Peled A; Petit I; Byk T; Hershkoviz R; Guetta E; Barkai G; Nagler A; Lapidot T
    Blood; 2001 May; 97(10):3283-91. PubMed ID: 11342460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients.
    Jetmore A; Plett PA; Tong X; Wolber FM; Breese R; Abonour R; Orschell-Traycoff CM; Srour EF
    Blood; 2002 Mar; 99(5):1585-93. PubMed ID: 11861272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engraftment potential into NOD/SCID mice of CD34+ cells derived from human fetal liver as compared to fetal bone marrow.
    Wilpshaar J; Noort WA; Kanhai HH; Willemze R; Falkenburg JH
    Haematologica; 2001 Oct; 86(10):1021-8. PubMed ID: 11602407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature.
    Park TS; Bhutto I; Zimmerlin L; Huo JS; Nagaria P; Miller D; Rufaihah AJ; Talbot C; Aguilar J; Grebe R; Merges C; Reijo-Pera R; Feldman RA; Rassool F; Cooke J; Lutty G; Zambidis ET
    Circulation; 2014 Jan; 129(3):359-72. PubMed ID: 24163065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditions that enable human hematopoietic stem cell engraftment in all NOD-SCID mice.
    Rice AM; Wood JA; Milross CG; Collins CJ; McCarthy NF; Vowels MR
    Transplantation; 2000 Mar; 69(5):927-35. PubMed ID: 10755552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engraftment of human hematopoietic precursor cells with secondary transfer potential in SCID-hu mice.
    Chen BP; Galy A; Kyoizumi S; Namikawa R; Scarborough J; Webb S; Ford B; Cen DZ; Chen SC
    Blood; 1994 Oct; 84(8):2497-505. PubMed ID: 7522631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice.
    Noort WA; Kruisselbrink AB; in't Anker PS; Kruger M; van Bezooijen RL; de Paus RA; Heemskerk MH; Löwik CW; Falkenburg JH; Willemze R; Fibbe WE
    Exp Hematol; 2002 Aug; 30(8):870-8. PubMed ID: 12160838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.